156 related articles for article (PubMed ID: 2563304)
1. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
[TBL] [Abstract][Full Text] [Related]
2. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
Cox RF; Waszczak BL
Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
Cox RF; Neumeyer JL; Waszczak BL
J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
[TBL] [Abstract][Full Text] [Related]
5. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
[TBL] [Abstract][Full Text] [Related]
6. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
Enz A; Goldstein M; Meller E
Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116
[TBL] [Abstract][Full Text] [Related]
7. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller E; Puza T; Miller JC; Friedhoff AJ; Schweitzer JW
J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
Meller E; Puza T; Diamond J; Lieu HD; Bohmaker K
J Pharmacol Exp Ther; 1992 Nov; 263(2):462-9. PubMed ID: 1359107
[TBL] [Abstract][Full Text] [Related]
10. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
[TBL] [Abstract][Full Text] [Related]
11. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
12. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
Meller E; Hizami R; Kreuter L
Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521
[TBL] [Abstract][Full Text] [Related]
13. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
Takano Y; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
[TBL] [Abstract][Full Text] [Related]
14. Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo.
Pineda J; Ruiz-Ortega JA; Ugedo L
J Pharmacol Exp Ther; 1997 May; 281(2):690-8. PubMed ID: 9152374
[TBL] [Abstract][Full Text] [Related]
15. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.
Meller E; Enz A; Goldstein M
Eur J Pharmacol; 1988 Oct; 155(1-2):151-4. PubMed ID: 2907486
[TBL] [Abstract][Full Text] [Related]
16. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
Meller E; Bordi F; Bohmaker K
Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
[TBL] [Abstract][Full Text] [Related]
17. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
Mestlin M; McDougall SA
Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
[TBL] [Abstract][Full Text] [Related]
18. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
Bohmaker K; Puza T; Goldstein M; Meller E
J Pharmacol Exp Ther; 1989 Jan; 248(1):97-103. PubMed ID: 2563295
[TBL] [Abstract][Full Text] [Related]
19. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
McDougall SA; Crawford CA; Nonneman AJ
Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Ekman A; Eriksson E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
